152 related articles for article (PubMed ID: 10602903)
21. Biweekly docetaxel and vinorelbine as first-line chemotherapy in metastatic breast cancer.
Mayordomo JI; Milla A; Morales S; Yubero A; Lorenzo A; Baena JM; Modolell A; Sanz J; Illarramendi J; Garcia MJ; Machengs I; Burrilo MA; Tres A
Clin Breast Cancer; 2004 Jun; 5(2):131-5. PubMed ID: 15245617
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.
Martí JL; Bueso P; Mayordomo JI; Isla MD; Saenz A; Escudero P; Murillo L; Filipovich E; Andres R; Tres A
Ann Oncol; 2001 Aug; 12(8):1061-5. PubMed ID: 11583186
[TBL] [Abstract][Full Text] [Related]
23. Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer.
Airoldi M; Cattel L; Pedani F; Marchionatti S; Tagini V; Bumma C; Recalenda V
Acta Oncol; 2003; 42(3):186-94. PubMed ID: 12852694
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure.
Martín M; Lluch A; Casado A; Garciía Carbonero I; de Paz L; Esteban C; Insa A; Alfonso R; García-Conde J; Diaz-Rubio E
Ann Oncol; 2000 Jan; 11(1):85-9. PubMed ID: 10690393
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
[TBL] [Abstract][Full Text] [Related]
26. Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study.
Oliva C; Bergnolo P; Inguì M; Bianco L; Pochettino P; Cutin SC; Boglione A; Dal Canton O; Garetto F; Comandone A
J Cancer Res Clin Oncol; 2010 Mar; 136(3):411-7. PubMed ID: 19727815
[TBL] [Abstract][Full Text] [Related]
27. Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factor.
Kornek GV; Haider K; Kwasny W; Lang F; Krauss G; Hejna M; Raderer M; Weinländer G; Depisch D; Scheithauer W
Br J Cancer; 1998 Sep; 78(5):673-8. PubMed ID: 9744509
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of an oxaliplatin/vinorelbine combination in patients with anthracycline- and taxane-pre-treated metastatic breast cancer.
Petit T; Benider A; Yovine A; Bougnoux P; Spaeth D; Maindrault-Goebel F; Serin D; Tigaud JD; Eymard JC; Simon H; Bertaux B; Brienza S; Cvitkovic E
Anticancer Drugs; 2006 Mar; 17(3):337-43. PubMed ID: 16520663
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L
J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277
[TBL] [Abstract][Full Text] [Related]
30. Phase I study of Doxil and vinorelbine in patients with advanced malignancies.
Laufman LR; Spiridonidis CH; Jones JJ; Rhodes V; Rossi K; Wallace K
Cancer Invest; 2004; 22(3):344-52. PubMed ID: 15493354
[TBL] [Abstract][Full Text] [Related]
31. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
Farhat F; Kattan JG; Ghosn M
Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of vinorelbine/doxorubicin as first-line therapy of advanced breast cancer.
Spielmann M; Dorval T; Turpin F; Antoine E; Jouve M; Maylevin F; Lacombe D; Rouesse J; Pouillart P; Tursz T
J Clin Oncol; 1994 Sep; 12(9):1764-70. PubMed ID: 8083698
[TBL] [Abstract][Full Text] [Related]
33. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
Zelek L; Barthier S; Riofrio M; Fizazi K; Rixe O; Delord JP; Le Cesne A; Spielmann M
Cancer; 2001 Nov; 92(9):2267-72. PubMed ID: 11745280
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant chemotherapy with ifosfamide, cisplatin, and vinorelbine in advanced squamous cell carcinoma of the cervix.
Vallejo CT; Pérez JE; Domínguez ME; Leone BA; Machiavelli MR; Lacava JA; Romero AO; Ortiz EH; Grasso S; Amato S; Rodríguez R; Barbieri M; Romero Acuña J; Focaccia G; Suttora G; Scenna M; Boughen JM; Romero Acuña LA; Langhi MJ
Am J Clin Oncol; 2000 Oct; 23(5):481-6. PubMed ID: 11039508
[TBL] [Abstract][Full Text] [Related]
35. Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients.
Ellis GK; Gralow JR; Pierce HI; Williams MA; Livingston RB
J Clin Oncol; 1999 May; 17(5):1407-12. PubMed ID: 10334525
[TBL] [Abstract][Full Text] [Related]
36. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
37. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancer.
Pronzato P; Queirolo P; Landucci M; Vaira F; Vigani A; Gipponi M; Cafiero F
Breast Cancer Res Treat; 1997 Jan; 42(2):183-6. PubMed ID: 9138607
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines.
Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L
Br J Cancer; 2005 Feb; 92(4):634-8. PubMed ID: 15668714
[TBL] [Abstract][Full Text] [Related]
40. Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study.
Serin D; Verrill M; Jones A; Delozier T; Coleman R; Kreuser ED; Mross K; Longerey B; Brandely M
Br J Cancer; 2005 Jun; 92(11):1989-96. PubMed ID: 15928659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]